Skip to main content
Clinical Trials/CTRI/2019/01/016913
CTRI/2019/01/016913
Not yet recruiting
Phase 4

A single blinded prospective randomised controlled trial on Tacrolimus Vs Advagraf immunosuppression in adult live donor liver transplantation.

Amrita Institute of medical sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Sponsor
Amrita Institute of medical sciences
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.All patients above 18 years
  • 2\.Patients who are recipient of primary liver allografts from a living donor.
  • 3\. Patients who are capable of understanding and giving written informed consent to be a part of the study.

Exclusion Criteria

  • 1\. Deceased donor liver transplant recepients
  • 2\. Multiorgan transplants
  • 3\. ABO incompatible grafts
  • 4\. Recent chemotherapy before transplantation
  • 5\. Intolerance to study medications
  • 6\. Pediatric transplant

Outcomes

Primary Outcomes

Not specified

Similar Trials